Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Preimplantation genetic testing is a rapidly growing area of fertility research commonly incorporated into IVF research workflows. PGT findings can determine chromosome presence and frequency in embryo biopsies, which provides scientific insight into reducing the time to pregnancy and decreasing miscarriage rates.
Preimplantation genetic testing-aneuploidy (PGT-A)
Preimplantation genetic testing-monogenic (PGT-M)
This session, from ESHRE 2024, covers advanced topics such as delivering premium preimplantation genetic testing (PGT) add‑ons to enhance traditional PGT, demystifying PGT‑A with a focus on invasive vs non‑invasive PGT‑A approaches, and exploring the implications of coelocentesis on fetal health, particularly in detecting chromosome aneuploidies and monogenic disorders.
In this roundtable, we focus on PGT for monogenic disorders (PGT-M) specifically within the public sector, analysing the presence of genetic mutations in single gene linked disorders.
In this on-demand roundtable, we are exploring the particulars of non-invasive and invasive PGT and experts in the field are sharing their insights on the advantages, challenges, and the evolving landscape of genetic testing.
In this talk you will gain an understanding on how to integrate a workflow for both PGT-A and PGT-M on NGS from a single embryo biopsy. Additionally, you will learn about our premium PGT-A analysis with SNP-based quality controls. Explore how SNPs can offer genetic insights on polyploidy, maternal contamination, and sibling identity.